To succeed in the pharmaceutical industry, insiders grasp that what you know and who you know are equally important. The best place to get the right answers and to stay ahead of the curve is at the Pharma CI Conference & Exhibition on September 17-18, 2013 in East Brunswick, New Jersey, USA.
Conference participants will benefit from the talented speaking faculty of expert speakers from prestigious pharma companies like Amylin, Aptalis, Astellas, AstraZeneca, Avanir, Bausch + Lomb, Bayer, Boehringer Ingelheim, CSL Behring, DARA Biosciences, Dendreon, DSM, Eisai, Endo, Ipsen, Johnson & Johnson, Lupin, Merck, Millennium, NPS, Pfizer, Regeneron, Roche, Sanofi, Sanofi Pasteur, Sarepta Therapeutics, Shire Human Genetics Therapy, Takeda, Teva, Upsher-Smith, Valeant, Vertex, ZIOPHARM Oncology, and many more! It’s also interesting to note that many fresh perspectives will be heard, especially as the stellar speaking faculty includes the addition of 25+ biopharma speakers who are first timers to the conference! Conference attendees will also benefit from the expertise of speakers from emerging, smaller biotechs, as well as new leaders from instantly recognizable big pharma companies
“It was very valuable hearing the “gurus” of pharma CI discuss what they predict will be the important issues for our industry in the future, and what we as CI professionals need to do to make sure our companies are prepared,” says a Boehinger Ingelheim participant.
“Your conference is by far the most valuable conference I've attended during my career,” says a Merial participant.
Last year's historic, sold-out event was witnessed by more than 300 top pharmaceutical executives. And now the 2013 Pharma CI Conference is already en route to an even more successful event this fall! This gathering is known for impactful networking for everyone who attends because we truly bring together all the intelligence industry's heavy hitters under one roof. This premier event is always the most talked-about and well-attended conference in the industry.
“The networking and collaboration amongst the healthcare industries is priceless. This conference allowed many of us to share common challenges and brainstorm ideas on how to bring CI to the next level for everyone competing in the Pharma/Med Device industries,” says a participant from ETHICON, a Johnson & Johnson company.
“It was the best pharma competitive intelligence or pharma business intelligence conference that I've attended in many years. It was just the right mix of topics and a fine selection of speakers,” praises a Pfizer attendee.
“This conference is an excellent way to catch up on the latest practices in the field, network with other CI professionals and discuss the latest innovations with vendors,” enthuses a participant from Millennium Pharmaceuticals
The Pharma CI Conference (pharmaciconference.com) is THE INDUSTRY'S GOLD STANDARD for senior level pharmaceutical, biotechnology, medical device, and diagnostics professionals seeking the latest news and the industry’s best networking opportunities.